Готові списки джерел за темами / Menopause Hormone therapy

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Добірка наукової літератури з теми "Menopause Hormone therapy"

Автор: Grafiati
Опубліковано: 4 червня 2021
Оновлено: 25 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Menopause Hormone therapy".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Menopause Hormone therapy"

1

J., V. Pinkerton. "HORMONE THERAPY FOR POSTMENOPAUSAL WOMEN." REPRODUCTIVE ENDOCRINOLOGY, no. 56 (December 30, 2020): 100–106. https://doi.org/10.18370/2309-4117.2020.56.100-106.

Повний текст джерела
Анотація:
Hormone therapy is recommended for relief from hot flashes or night sweats in women younger than age 60 years or those who entered menopause within 10 years of seeking treatment. Hormone therapy also can reduce bone loss and the risk of fractures; offer a potential cardioprotective benefit; and alleviate the genitourinary symptoms of menopause, including dysfunction of the bladder and irritation of the vagina and vulva. For women with early menopause without contraindications, hormone therapy is recommended until at least the average age of natural menopause. Observational studies suggest that
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Pearce, Jane, Keith Hawton, and Fiona Blake. "Psychological and Sexual Symptoms Associated with the Menopause and the Effects of Hormone Replacement Therapy." British Journal of Psychiatry 167, no. 2 (1995): 163–73. http://dx.doi.org/10.1192/bjp.167.2.163.

Повний текст джерела
Анотація:
BackgroundThere is considerable inconsistency in the results of studies of the psychological and sexual sequelae of the menopause and their treatment.MethodA search of the literature on Medline was made of studies of psychological symptoms in women who were either naturally or surgically menopausal or who were receiving hormone replacement therapy for menopausal symptoms.ResultsThere is evidence of a small increase in psychological morbidity (not usually amounting to psychiatric disorder) preceding the natural menopause and following the surgical menopause. Psychosocial as well as hormonal fac
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Riya, Fathima V. Christy T. Chacko A. R. Shabaraya. "Menopausal Hormone Therapy And Its Awareness In Women." International Journal in Pharmaceutical Sciences 2, no. 9 (2024): 986–93. https://doi.org/10.5281/zenodo.13820255.

Повний текст джерела
Анотація:
Menopause results from cease in ovarian follicular function and marks the end of menstruation. Most women experience menopause between the ages of 40 and 58 years. Hormone replacement therapy (HRT) in the form of estrogen alone or combined estrogen and progesterone formulations has been widely used to treat menopausal symptoms to improve women’s quality of life, control their climacteric symptoms and prevent osteoporosis. This study aims to investigate the knowledge and awareness of women towards menopausal hormone replacement therapy and its role in the management of menopause. A cross-
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Noble, Nikki. "Hormone replacement therapy: update and practical prescribing." Practice Nursing 32, no. 4 (2021): 148–56. http://dx.doi.org/10.12968/pnur.2021.32.4.148.

Повний текст джерела
Анотація:
Peri-menopause and menopause are a normal part of ageing. Nikki Noble gives an overview of hormone replacement therapy and practical prescribing tips Menopause is a physiological event of ovarian failure due to a loss of ovarian follicular activity. This leads to a lack of oestrogen, resulting in the cessation of menstruation and loss of reproductive function. This article discusses the symptoms of menopause and treatment with hormone replacement therapy. This includes practical prescribing, side effects and long-term benefits and risks. The current shortages of hormone replacement therapy are
Стилі APA, Harvard, Vancouver, ISO та ін.
5

С., А. Шурпяк. "Principles of management of premature and surgical menopause in women with initial reproductive health problems." Reproductive Endocrinology, no. 41 (June 15, 2018): 48–54. https://doi.org/10.18370/2309-4117.2018.41.48-54.

Повний текст джерела
Анотація:
Menopausal hormone therapy remains the most effective treatment for vasomotor symptoms and genitourinary menopausal syndrome and has been shown to prevent bone loss and destruction. This circumstance makes it possible to consider menopausal hormone therapy as the main method for the treatment of premature and surgical menopause. It is important to note that despite the similarity of the long-term consequences bilateral oophorectomy and premature fading in ovarian function differ significantly in the dynamics of the hormones concentration decrease. The risks of menopausal hormone therapy vary d
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Romanenko, T. H., G. M. Zhaloba, and N. V. Yesyp. "Menopause hormone therapy (Literature review)." HEALTH OF WOMAN, no. 6(142) (July 29, 2019): 87–91. http://dx.doi.org/10.15574/hw.2019.142.87.

Повний текст джерела
Анотація:
Practitioners in the fields of obstetrics and gynecology get used to look at the women’s health from the point of view of maintaining her reproductive potential and assistance in its fulfillment. Less attention is paid to the problem of reproductive function`s descent. Common changes during the menopausal transition were out of specialists` focus and women were left with no choice but to deal with those problems on their own. Nevertheless, global tendency of population ageing and growing awareness about the importance of professional and cultural activities of these women makes it important to
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Batista, Nertan Ribeiro, Alessandra Honorato Aguiar, Ana Carolina da Ponte Cervo, et al. "HORMONE THERAPY DURING MENOPAUSE: BENEFITS AND INDICATIONS." Periódicos Brasil. Pesquisa Científica 3, no. 2 (2024): 264–80. http://dx.doi.org/10.36557/pbpc.v3i2.76.

Повний текст джерела
Анотація:
Descrever os benefícios e as principais indicações para o tratamento de reposição de hormônios durante a menopausa. Métodos: O presente estudo foi realizado mediante uma revisão sistemática da literatura, que aborda os benefícios da terapia hormonal na menopausa, por meio das bases de dados EMBASE e MEDLINE, através dos descritores DeCS/MeSH “Hormone Replacement Therapy” e “Menopause”utilizando o operador booleano “and” entre os descritores, como representado a seguir: “Hormone Replacement Therapy” and “Menopause”. Resultados/Discussão: Após as etapas descritas na metodologia do estudo, foram
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Noble, Nikki. "Hormone replacement therapy: update and practical prescribing." Journal of Prescribing Practice 2, no. 2 (2020): 91–97. http://dx.doi.org/10.12968/jprp.2020.2.2.91.

Повний текст джерела
Анотація:
Menopause is a physiological event of ovarian failure due to a loss of ovarian follicular activity. This leads to a lack of oestrogen, resulting in the cessation of menstruation and loss of reproductive function. This article discusses the symptoms of menopause and treatment with hormone replacement therapy. This includes practical prescribing, side effects and long term benefits and risks. The current shortages of hormone replacement therapy are also addressed. The aim of this article is to enable healthcare professionals to define menopause and gain an understanding of the symptoms associate
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Topo, Paivi, and Elina Hemminki. "Is menopause withering away?" Journal of Biosocial Science 27, no. 3 (1995): 267–76. http://dx.doi.org/10.1017/s0021932000022793.

Повний текст джерела
Анотація:
SummaryMenopause (cessation of menstruction) and the period surrounding it (climacterium) are often defined retrospectively by asking a woman the date of her last menstrual period (LMP). Based on a survey of 2000 women aged 45–64 in 1989 in Finland, this study examines (1) the relation between these definitions and women's own definitions of their climacteric status and of the cessation of menstruction and (2) the effect of menopausal and postmeno pausal hormone therapy and hysterectomy on the definition of menopause and climacterium. Agreement of the woman's own definition of her climacteric
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Leshchenko, O. Ya. "Menopausal transition: ambiguous definitions, diagnostic markers, and treatment strategies." Russian Journal of Woman and Child Health 8, no. 2 (2025): 106–13. https://doi.org/10.32364/2618-8430-2025-8-2-3.

Повний текст джерела
Анотація:
Premenopause (or menopausal transition preceding menopause) is characterized by gradual depletion of ovarian follicular reserve, altered response to gonadotropin hormones, significant fluctuations of hormone levels, and irregular menstruation. Typically, a clinician is faced with a number of issues and difficulties regarding diagnosis and therapy in such patients Aim: to discuss primary pathophysiological processes associated with the menopausal transition, as well as a place of non-hormonal treatment of comorbidities at this stage. A systematic search for guidelines, approaches, and consensus
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Menopause Hormone therapy"

1

Antoine, Caroline. "Menopause, breast cancer and menopausal treatments." Doctoral thesis, Universite Libre de Bruxelles, 2018. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/271843.

Повний текст джерела
Анотація:
RESUME Introduction: Le cancer du sein (CS) est le cancer le plus fréquent chez la femme. Le risque de CS est influencé par de nombreux facteurs. Le traitement hormonal de la ménopause (THM) est l’un d’entre eux. Le risque de CS associé au THM varie probablement en fonction de la population traitée, du type de traitement utilisé, de la durée du traitement et du moment où il est instauré par rapport au début de la ménopause. Il existe des alternatives au THM pour soulager les symptômes de la ménopause. Quelques traitements ont montré une certaine efficacité mais présentent des effets secondaire
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Homer, Natalie. "Erythocyte oxidative stress : focus on hormone replacement therapy." Thesis, University of Strathclyde, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.273852.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Rhoads, Misty Lynn. "Hormone replacement therapy : attitudes, knowledge, and usage by perimenopausal and postmenopausal women /." View online, 2005. http://repository.eiu.edu/theses/docs/32211131275302.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Towne, Cheryl Luann Rush. "Older women's beliefs about hormone replacement therapy : a qualitative study /." View online, 2000. http://repository.eiu.edu/theses/docs/32211130976791.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Fischer, Mary A. "Women’s Experiences of Discontinuing Hormone Therapy: A Dissertation." eScholarship@UMMS, 2011. https://escholarship.umassmed.edu/gsn_diss/23.

Повний текст джерела
Анотація:
Although many women find relief from menopause through hormone therapy (HT), current guidelines recommend that HT be used only for short-term relief of symptoms. Women who attempt to stop HT often encounter troublesome recurrent symptoms leading to a diminished quality of life (QoL); 25% of women who discontinue eventually resume HT. Unfortunately, there is little information for women and their health care providers as to the best way to discontinue HT or how to prepare and guide women through this process. An in-depth description of women‘s experiences during HT discontinuation and the facto
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Yeung, Wing-kwan Rosa. "Adjunctive effect on hormone replacement therapy on periodontal treatment responses in postmenopausal women." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B3765195X.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Ballard, Karen Dawn. "Women on the verge of HRT : factors influencing women's decisions about taking hormone replacement therapy." Thesis, Royal Holloway, University of London, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.396150.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Yeung, Wing-kwan Rosa, and 楊穎筠. "Adjunctive effect on hormone replacement therapy on periodontal treatment responses in postmenopausal women." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B3765195X.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Thompson, Jennifer Jo, Cheryl Ritenbaugh, and Mark Nichter. "Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making." BIOMED CENTRAL LTD, 2017. http://hdl.handle.net/10150/626039.

Повний текст джерела
Анотація:
Background: In recent years, compounded bioidentical hormone therapy (CBHT) has emerged as a popular alternative to manufactured, FDA approved hormone therapy (HT)-despite concerns within the medical community and the availability of new FDA approved "bioidentical" products. This study aims to characterize the motivations for using CBHT in a U.S. sample of ordinary midlife women. Methods: We analyze data collected from 21 current and former users of CBHT who participated in a larger qualitative study of menopausal decision-making among U.S. women. Interviews and focus groups were audio-recorde
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Sanders, Sharon Lea. "The effectiveness of hormone replacement therapy in the treatment of depressed mood and depressive disorders occurring during the climacteric /." [St. Lucia, Qld.], 2002. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe16707.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Menopause Hormone therapy"

1

Buckman, Rob. Todo lo que hay que saber sobre--: La menopausia y el tratamiento hormonal sustitutorio. Planeta, 2001.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

R, Johnson Susan, ed. Menopause and hormone replacement therapy. Saunders, 1997.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Nanette, Santoro, and Chervenak Judi Lee, eds. Menopause and hormone replacement therapy. Saunders, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Hawkins, Amy Lee. Replacing hormone replacements: Your bioidentical hormone solution. Sunrise River Press, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

D, Critchley Hilary O., Gebbie Ailsa, and Beral V, eds. Menopause and hormone replacement. RCOG, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Obstetrics, Consultant, Senior Lecturer in Obstetrics, and Juliet E. Compston MD FRCPath FRCP FMedSci. Hormone Replacement Therapy and the Menopause. Edited by Michael S. Marsh MD MRCOG. Taylor & Francis, 1988. http://dx.doi.org/10.4324/9780203213735.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Smith, Roger. The menopause and hormone replacement therapy. Dunitz, 1993.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Smith, Roger N. J. The menopause and hormone replacement therapy. 2nd ed. Dunitz, 1998.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Clinic, Marie Stopes, ed. Menopause & HRT. Ward Lock, 1994.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Genazzani, A. R. Hormone Replacement Therapy and Neurological Function. Informa Healthcare, 2003.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Menopause Hormone therapy"

1

Kennard, Elizabeth A. "Hormone Replacement Therapy." In Menopause. Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-246-3_9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Geraghty, Patricia. "Menopause Hormone Therapy." In Each Woman’s Menopause: An Evidence Based Resource. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-85484-3_6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Lambrinoudaki, Irene, and Eleni Armeni. "Menopause Hormone Therapy Customization." In Pre-Menopause, Menopause and Beyond. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-63540-8_22.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Ashraf, Asna Beg. "Prescribing Menopausal Hormone Therapy." In Management of Menopause. Springer Nature Singapore, 2024. https://doi.org/10.1007/978-981-96-0239-1_26.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Quereda, Francisco. "Hormone Therapy (I): Estrogens, Progestogens, and Androgens." In Menopause. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-59318-0_11.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Palacios, Santiago, and Mariella Lilue. "Hormone Therapy (II): Tibolone, The TSEC Concept." In Menopause. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-59318-0_12.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Navarro-Pardo, Esperanza, Tomi S. Mikkola, Tommaso Simoncini, Marta Millán, María Dolores Juliá, and Antonio Cano. "The Impact of Hormone Therapy on Health." In Menopause. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-59318-0_14.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Quereda, Francisco. "Hormone Therapy (I): Estrogens, Progestogens, and Androgens." In Menopause. Springer Nature Switzerland, 2025. https://doi.org/10.1007/978-3-031-83979-5_11.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Paciuc, John. "Hormone Therapy in Menopause." In Advances in Experimental Medicine and Biology. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-38474-6_6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Palacios, Santiago, and Mariella Lilue. "Hormone Therapy (II): Tibolone and the TSEC Concept." In Menopause. Springer Nature Switzerland, 2025. https://doi.org/10.1007/978-3-031-83979-5_12.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Menopause Hormone therapy"

1

Bunting, Haley A., Ryan T. Cassilly, Brian Jin, et al. "Effect of Hormone Therapy on Tensile Strain of the Macaque Inferior Glenohumeral Ligament." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53531.

Повний текст джерела
Анотація:
The effect of hormone treatment on the material properties of ligaments has been extensively studied for the anterior cruciate ligament (ACL). However, there have been few studies on the effects of hormones on the material properties of the shoulder. Shoulder ligaments contribute to overall shoulder stability, and a change in ligament properties could contribute to a change in overall shoulder laxity. Cynomolgus monkeys have served as nonhuman primate models in studies examining the effects of hormone replacement therapy on the cardiovascular system, as well as serving as a model for menopause
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Gardner, Thomas R., Ryan T. Cassilly, Brian Jin, et al. "Effect of Estrogen on Viscoelastic Properties of the Anterior Pouch of the Macaque Animal Model of the Inferior Glenohumeral Ligament." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206835.

Повний текст джерела
Анотація:
The effect of hormone treatment on the material properties of ligaments has been extensively studied for the anterior cruciate ligament (ACL). However, there have been very few studies on the effects of hormones on the material properties of the shoulder. These shoulder ligaments contribute to overall shoulder stability, and a change in ligament properties could contribute to a change in overall shoulder laxity. This study uses female cynomologus macaque (Macaca fascicularis) monkeys as an animal model of the human shoulder to determine if estrogen has an effect on the viscoelastic properties
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Vieira, Amanda Cristina de Souza, Antônio Pedro Oliveira de Vasconcelos, Jaqueline Maria Pinheiro de Araujo, et al. "EPIDEMIOLOGICAL RELATIONSHIP BETWEEN HORMONE REPLACEMENT THERAPY AND BREAST CANCER." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2090.

Повний текст джерела
Анотація:
Objective: The aim of this study was to epidemiologically analyze the hormone replacement therapy (HRT) and the emergence of breast cancer. Methodology: This is an article review from the databases such as LILACS, SciELO, Bireme, and Medscape, utilizing the keywords: menopause, HRT, breast cancer and complications, employing the use of connectors when necessary. This review aims to elucidate what has been published in the last years about the usage of hormone therapy and the emergence of breast cancer since there are disagreements between the literature. Results: The analysis displayed positiv
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Jang, J.-H., N. Arora, G. Hanley, and J. Kwon. "P163 Hormone replacement therapy use after premature surgical menopause and impact on subsequent health services." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.224.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Sousa-Lima, Renata, Isabella Machado, Luiz-Francisco Freitas, Gilson Veloso, and Angelica Rodrigues. "EP089/#784 Low use of hormone therapy in women with early menopause arising from treatment for cervical cancer." In IGCS 2022 Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/ijgc-2022-igcs.180.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Li, Tricia, Jiali Han, and Chunyan He. "Abstract 1741: The association between menopause symptoms and risk of postmenopausal breast cancer among non-users of hormone therapy." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-1741.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Zhang, P., and J. G. Zein. "Menopausal Hormone Replacement Therapy and Risk of Asthma." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7089.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Pratt, Sheila Alhana, Valeria Sanabria, Ana Soskin, Aurora Rocio Rizzi, and Marcos Cabrera. "ADENOID CYSTIC CARCINOMA OF THE BREAST." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1014.

Повний текст джерела
Анотація:
Introduction: Adenoid cystic adenoid carcinoma (ACC) of the breast is a rare variant that occurs in large series only in less than 1% of the patients. It has favorable prognosis and morphological resemblance to tumors originating in the salivary glands. Histopathological diagnosis is based on a mixture of proliferating glands, which correspond to the adenoid component and the replication of the basal membrane in the form of cylinders established by the pseudoglandular component. It usually occurs in adult women. Its form of clinical presentation is a painless breast nodule, located in the retr
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Cordina-Duverger, Emilie, Thérèse Truong, Antoinette Anger, et al. "Abstract 655: Menopausal hormone therapy and breast cancer risk: The CECILE Study." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-655.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Jordahl, Kristina M., David R. Doody, Yuzheng Zhang, et al. "Abstract 2772: Hormone replacement therapy and genome-wide DNA methylation among post-menopausal women." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-2772.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Menopause Hormone therapy"

1

Boulin, Tiphaine, Isla Whitcroft, and Hannah Moody. HRT, menopause and breast cancer. Breast Cancer UK, 2024. https://doi.org/10.71450/45513910.

Повний текст джерела
Анотація:
Hormone replacement therapy (HRT) is used to manage the symptoms of menopause. It has been associated with an increased risk of developing breast cancer; however, this risk varies according to the type of HRT and duration of use. Evidence suggests that oestrogen-only HRT has little to no increased risk of breast cancer; however, it is generally only prescribed to people who have had a hysterectomy as it carries an increased risk of uterine cancer. Combined HRT is associated with a duration-dependent increase in breast cancer risk when used over five years. This increase in risk then reduces af
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Rada, Maria Patricia, Alexandra Caseriu, Roxana Crainic, and Stergios K. Doumouchtsis. A critical appraisal and systematic review of clinical practice guidelines on hormone replacement therapy for menopause: assessment using the Appraisal of Guidelines for Research and Evaluation (AGREE II) Instrument. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0089.

Повний текст джерела
Анотація:
Review question / Objective: To assess the quality of clinical practice guidelines (CPC) on hormone replacement therapy for menopause using the AGREE II instrument and to provide a summary of recommendations. Information sources: Literature searches using MEDLINE, Embase, Scopus, Geneva Foundation for Medical Education and Research from inception to date will be searched. The search terms include guidelines / guidance / recommendation and hormone replacement therapy related keywords and MeSH terms. National and international organizations websites will be searched individually. Additional sear
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Danan, Elisheva R., Susan Diem, Catherine Sowerby, et al. Genitourinary Syndrome of Menopause: A Systematic Review. Agency for Healthcare Research and Quality (AHRQ), 2024. http://dx.doi.org/10.23970/ahrqepccer272.

Повний текст джерела
Анотація:
Objectives. To conduct a systematic review of evidence regarding genitourinary syndrome of menopause (GSM) screening, treatment, and surveillance. Data sources. Ovid/Medline®, Embase®, and EBSCOhost/CINAHL® from database inception through December 11, 2023. Review methods. We employed methods consistent with the Agency for Healthcare Research and Quality Evidence-based Practice Center Program Methods Guidance to identify studies and synthesize findings for Key Questions related to screening for GSM, effectiveness and harms of U.S.-available interventions for GSM, appropriate followup intervals
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Stute, Petra, Susanne Theis, Argy Kolokythas, et al. Systematic review on the influence of progestogens on the endometrium. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.6.0028.

Повний текст джерела
Анотація:
Review question / Objective: The objective of this systematic review is to summarize published data from randomized controlled trials regarding the influence of a combined menopausal hormone therapy on the endometrium with specific focus on endometrial hyperplasia and endometrial cancer incidence. Eligibility criteria: The following progestagens will be investigated: Norethisterone (acetate) = NET(A), Dienogest = DNG, Dydrogesterone = DYD, Micronized Progesterone = MP, Drospirenone = DRSP, Levonorgestrel = LNG, Cyproterone acetate = CPA, Medroxyprogesterone acetate = MPA, Chlormadinone acetate
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Wang, Xinrun, Tianye Li, Xuechai Bai, Yun Zhu, and Meiliang Zhang. Therapeutic prospect on umbilical cord mesenchymal stem cells in animal model with primary ovarian insufficiency: A meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.5.0075.

Повний текст джерела
Анотація:
Review question / Objective: Participants: experiment POI animal models; Interventions: human umbilical cord mesenchymal stem cells; Comparisons: POI animal models without hUCMSC therapy; Outcomes: estrous cycle situation, serum sex hormone level and ovarian follicle count; Studies: randomized controlled animal study; The aim of the review is to figure out whether hUCMSC can recover ovarian function in POI animal models. Condition being studied: Primary ovarian insufficiency (POI) is a syndrome characterized by reduced or absent ovarian function (hypogonadism) and elevated levels of gonadotrop
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Angrist, Joshua, Amanda Kowalski, Ljubica Ristovska, and Marcia Stefanick. Instrumental Variables Methods Reveal Larger Effects of Menopausal Hormone Therapy in the Landmark Women’s Health Initiative Clinical Trial. National Bureau of Economic Research, 2025. https://doi.org/10.3386/w33635.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Shlyakhto, Evgeny V., Gennady T. Sukhikh, Vladimir N. Serov, et al. RUSSIAN ELIGIBILITY CRITERIA PRESCRIBING MENOPAUSAL HORMONAL HORMONES THERAPY FOR PATIENTS WITH CARDIOVASCULAR AND METABOLIC DISEASES. CONSENSUS DOCUMENT OF THE RUSSIAN CARDIOLOGICAL SOCIETY, RUSSIAN SOCIETY OF OBSTETRICIANS AND GYNECOLOGISTS, RUSSIAN ASSOCIATION OF ENDOCRINOLOGISTS, EURASIAN ASSOCIATION OF THERAPISTS, ASSOCIATION OF PHLEBOLOGISTS OF RUSSIA. Endocrinology Research Center, 2024. http://dx.doi.org/10.14341/critrcd2024.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Menopause Hormone therapy" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії